Bank of America analysts last year underlined how the firms making syringes used to inject vaccines could witness explosive growth, as well as those who planned to distribute the vaccine in the hundreds of millions across the European heartland and Asia. Industry experts cited in the study detailed that North American firms were expected to lead the market in this regard, with European and Asian firms following close behind. Market Study claimed that new outbreaks of the virus and increased government purchases drove the positive market forecast. The chief of India-based Serum Institute, one of the largest vaccine producers in the world, last month spoke about the US restrictions on the export of raw materials needed for the COVID-19 vaccine. Vaccine raw material shortages could spell disaster for the nation and the firms producing it.
Here is Insider Monkey’s list of 10 Best Vaccine Stocks to Buy Now with this context in mind. AbbVie Inc. markets two new drugs in oncology and immunology. It makes Skyrizi as well, a drug to treat moderate to severe plaque psoriasis. AbbVie is one of the few stocks that have managed double-digit payout increases this year. Gilead Sciences, Inc. is a California-based biopharmaceutical company that concentrates on the research and development of antiviral drugs used to treat HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. The company operates in several countries around the world. CureVac N.V. makes vaccines for infectious diseases and drugs to treat cancer and rare diseases. The company has partnerships with several other biopharma firms for collaboration on research and development. Inovio Pharmaceuticals is a Pennsylvania-based biopharma firm that concentrates on developing and selling synthetic DNA products for treating cancers and infectious diseases. On April 15, the firm’s shares were up 17% as the firm announced that it had developed a DNA COVID-19 vaccine that demonstrated an effective response against the original strain of the coronavirus and several other variants of the disease. Novavax is a drug company trying to develop nanoparticle vaccines and adjuvants. Novavax is especially known for using recombinant vaccine technology to develop new products. For details, click 10 Best Vaccine Stocks to Buy Now.
